No Data
Mizuho Securities Maintains GoodRx(GDRX.US) With Hold Rating
TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10
Truist Financial Maintains GoodRx(GDRX.US) With Hold Rating
GoodRx Holdings: Navigating Leadership Transition and Legislative Uncertainty
GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
GoodRx Holdings: Buy Rating Reaffirmed Amid Leadership Stability and Growth Prospects